BioPharm International Editorial Advisory Board

The following biopharma industry experts serve as members of the BioPharm International Editorial Advisory Board.

• K. A. Ajit-Simh, President, Shiba Associates
• Madhavan Buddha, Freelance Consultant
• Rory Budihandojo, Independent Consultant
• Suggy S. Chrai, President and CEO, The Chrai Associates
• Uwe Gottschalk, Vice-President, Chief Technology Officer, Pharma/Biotech, Lonza AG
• Fiona M. Greer, Senior Consultant, BioPharmaSpec (UK)
• Rajesh K. Gupta, Vaccinnologist and Microbiologist
• Denny Kraichely, Department Head, Analytical Project Leadership, Merck Vaccines
• Stephan O. Krause, Head of Product Quality Group, AstraZeneca Biologics
• Steven S. Kuwahara, Principal Consultant, GXP BioTechnology LLC
• Eric S. Langer, President and Managing Partner, BioPlan Associates, Inc.
• Howard L. Levine, Senior Managing Director, BDO, National Leader, BioProcess Technology Group
• Hank Liu, Head of Quality Control, Sanofi Pasteur
• Herb Lutz, Principal Consulting Engineer, Merck Millipore
• Hanns-Christian Mahler, Head Drug Product Services, Lonza AG
• Jerold Martin, Independent Consultant
• Hans-Peter Meyer, Lecturer, University of Applied Sciences and Arts Western Switzerland, Institute of Life Technologies
• K. John Morrow, President, Newport Biotech
• David Radspinner, VP/GM Global Commercial Transition, Cytiva
• Tom Ransohoff, Managing Director, Industry Specialty Services, BioProcess Technology Group, BDO
• Anurag Rathore, Biotech CMC Consultant, Faculty Member, Indian Institute of
  Technology
• Susan J. Schniepp, Executive Vice President of Post-Approval Pharma and Distinguished Fellow, Regulatory Compliance Associates, Inc.
• Tim Schofield, Consultant, CMC Sciences, LLC
• Paula Shadle, Principal Consultant, Shadle Consulting
• Michiel E. Ultee, Principal, Ulteemit BioConsulting
• Thomas J. Vanden Boom, Independent Biotechnology Consultant
• Steven Walfish, Principal Scientific Liaison, USP